Efficacy of Jiaotai Gujing Formula combined with psychosexual therapy for premature ejaculation: a randomized controlled trial

Background: Premature ejaculation (PE) is a prevalent male sexual dysfunction with significant psychological and relational impacts. While selective serotonin reuptake inhibitors are commonly used as first-line treatments, their adverse effects and limited efficacy necessitate alternative approaches. Traditional Chinese medicine, particularly Jiaotai Gujing Formula (JGF), has shown promise in preclinical studies, but its combined effect with psychosexual therapy remains underexplored. Methods: This randomized controlled trial enrolled 120 PE patients, allocated equally to a treatment group (JGF plus psychosexual therapy) and a control group (JGF alone). Psychosexual therapy included structured counseling and assessments of anxiety and depression. Primary outcomes were measured by intravaginal ejaculatory latency time (IELT), with secondary outcomes including Hamilton Anxiety (HAM-A) and Hamilton Depression (HAM-D) scales, Chinese Medicine Symptom Score (CMSS), and Clinical Global Impression (CGI). Results: Of 110 completers (56 in the treatment group, 54 in the control group), the treatment group demonstrated superior outcomes. IELT increased significantly in both groups (211.11 ± 103.22 vs. 174.74 ± 86.82 seconds, p < 0.05), with a greater improvement observed in the treatment group (p < 0.05). HAM-A and HAM-D scores decreased more markedly in the treatment group (7.70 ± 3.25 and 6.45 ± 1.92, respectively) than in the control group (9.89 ± 3.94 and 8.59 ± 4.47, p < 0.05). After treatment, the CMSS of both groups was significantly lower than that at baseline (p < 0.05). However, there were no significant differences between the two groups in CGI scores. Safety profiles were favorable, with no severe adverse events reported. Conclusions: JGF combined with psychosexual therapy significantly prolongs IELT and alleviates psychosomatic symptoms in PE patients, offering a safe and effective integrative treatment. Clinical Trial Registration: This study was registered in ITMCTR (registration number: ITMCTR2024000718) and can be accessed at http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=238e5723-9556-422b-ac9f-0c8c41ecdc0b.

Premature ejaculation; Traditional Chinese medicine; Psychosexual therapy; Randomized controlled trial; Anxiety; Depression

[1] Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel AW, Adaikan PG, et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). The Journal of Sexual Medicine. 2014; 11: 1392–1422.

[2] Shaher H, Noah K, Abdelzaher M, Kandil W, Ahmed IS, S Nouh I. Is bulbospongiosus muscle botox injection safe and effective in treating lifelong premature ejaculation? Randomized controlled study. World Journal of Urology. 2024; 42: 218.

[3] Shariev A, Savdie R, Hart K. The effects of steady Freddy, a lidocaine-based pump spray for the treatment of premature ejaculation (PE). American Journal of Men’s Health. 2022; 16: 15579883221145245.

[4] Wang H, Chang H, Wang A, Luo D, Huang C, Huang J, et al. Exploring the efficacy of acupuncture for tension-type headache: a literature review and insights from traditional Chinese medicine. Journal of Oral & Facial Pain and Headache. 2024; 38: 11–23.

[5] Wang H, Lei X, Ma D, Zhao Z, Wang A, Du G, et al. Efficacy of acupuncture for psychogenic erectile dysfunction: a randomized, sham-controlled trial. Basic and Clinical Andrology. 2023; 33: 40.

[6] Wang H, Chang H, Wang A, Guo J, Wang F, Chung E. A narrative review of acupuncture for sexual dysfunction: perspective of traditional Chinese medicine. Translational Andrology and Urology. 2024; 13: 2587–2600.

[7] Wang H, Yan B, Zhao M, Guo J, Zhang J. Efficacy of acupuncture in the treatment of psychogenic erectile dysfunction: study protocol for a randomized control trial. Journal of Men’s Health. 2023; 19: 31–38.

[8] Chang X, Xu M, Chen Y, Che C, Du Y, Wang X. Selective serotonin reuptake inhibitors combined with traditional Chinese medicine for premature ejaculation: a systematic review and meta-analysis. Andrology. 2023; 11: 112–124.

[9] Sun D, Zhao F, Zhang C, Wang S, Li M, Yu Q. Clinical study on the efficacy of Jiaotai Gujing decoction on premature ejaculation with syndrome of Xin-Shen incoordination. Chinese Journal of Andrology. 2021; 35: 25–28. (In Chinese)

[10] Hobbs K, Symonds T, Abraham L, May K, Morris MF. Sexual dysfunction in partners of men with premature ejaculation. International Journal of Impotence Research. 2008; 20: 512–517.

[11] Yang Y, Lu Y, Song Y, Chen H, Liu X. Correlations and stratification analysis between premature ejaculation and psychological disorders. Andrologia. 2019; 51: e13315.

[12] Xu P, Wang J, Wang H, Zhang R, Pang K. Research progress on the treatment of premature ejaculation by integrated traditional Chinese and Western medicine. Revista Internacional de Andrología. 2024; 22: 24–31.

[13] Hackett GI, Kirby M, Schartau P, Ossei-Gerning N, David J, Lee WG. British society for sexual medicine (BSSM) position statement on premature ejaculation. World Journal of Men’s Health. 2025; 43: 510–522.

[14] Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al.; EAU Working Group on Male Sexual and Reproductive Health. European association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. European Urology. 2021; 80: 333–357.

[15] Wang J, Yan C, Zhao Z, Chen H, Shi Z, Du Q, et al. Sexual dysfunction in patients with myasthenia gravis. Journal of Neuroimmunology. 2021; 358: 577669.

[16] Althof S, Rosen R, Harty B, Osterloh IH, Muirhead GJ, McMahon C. Objective and subjective measures of premature ejaculation: how closely do they correspond and how well are the subjective measures recalled? The Journal of Sexual Medicine. 2020; 17: 634–644.

[17] Xu Y, Liu T, Qiao Y, Xiang ZL, Xue JG, Huang XF, et al. Correlations between resting-state brain functional characteristics and TCM syndrome in premature ejaculation patients with heart-kidney disharmony. National Journal of Andrology. 2022; 28: 516–523. (In Chinese)

[18] Akinsal EC, Baydilli N, Tosun H, Kızılay E, Sönmez G. Sexual functions in men with congenital bilateral absence of the vas deferens: a retrospective cross-sectional study with fertile men. Urology Journal. 2025; 22: 44–49.

[19] Demirci A, Hızlı F, Hamurcu HD, Başar H. Erectile dysfunction, anxiety, perceived stress, and insomnia are more common among acquired premature ejaculation patients compared to other premature ejaculation syndromes. Andrology. 2023; 11: 425–432.

[20] Liao WC, Cheng WM, Fan YH, Liou YJ. Impact of type D personality and depressive symptoms on premature ejaculation in young adult males. Sexual Medicine. 2023; 11: qfad055.

[21] Kempeneers P, Andrianne R, Cuddy M, Blairy S. Sexual cognitions, trait anxiety, sexual anxiety, and distress in men with different subtypes of premature ejaculation and in their partners. Journal of Sex & Marital Therapy. 2018; 44: 319–332.

[22] Sathyanarayana Rao TS, Darshan MS, Tandon A. An epidemiological study of sexual disorders in south Indian rural population. Indian Journal of Psychiatry. 2015; 57: 150–157.

[23] Jaén SF, Rodríguez González JM, Espinosa García A. Sexual abuse and dysfunction in people with addiction problems and the general population. A descriptive study. Revista Internacional de Andrología. 2024; 22: 21–26.

[24] Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. The Journal of Sexual Medicine. 2006; 3: 309–317.

[25] Althof SE. Psychosexual therapy for premature ejaculation. Translational Andrology and Urology. 2016; 5: 475–481.

[26] Mohammadi Z, Maasoumi R, Vosoughi N, Eftekhar T, Soleimani M, Montazeri A. The effect of the EX-PLISSIT model-based psychosexual counseling on improving sexual function and sexual quality of life in gynecologic cancer survivors: a randomized controlled clinical trial. Supportive Care in Cancer. 2022; 30: 9117–9126.

[27] Pavone C, Abbadessa D, Gambino G, Scaduto G, Vella M. Premature ejaculation: pharmacotherapy vs group psychotherapy alone or in combination. Archivio Italiano di Urologia e Andrologia. 2017; 89: 114–119.

[28] McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, et al. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. The Journal of Sexual Medicine. 2011; 8: 524–539.

[29] Castiglione F, Albersen M, Hedlund P, Gratzke C, Salonia A, Giuliano F. Current pharmacological management of premature ejaculation: a systematic review and meta-analysis. European Urology. 2016; 69: 904–916.

[30] Cai T, Gallelli L, Verze P, Salonia A, Palmieri A. Prilocaine/lidocaine spray for the treatment of premature ejaculation: a dose- and time-finding study for clinical practice use. International Journal of Impotence Research. 2023; 35: 378–384.

[31] Almekaty K, Ghaith A, Ragab M, Rashed A, Hagras A, Ghoneem A, et al. Effect of bulbospongiosus muscle injection with botulinum—a toxin for treatment of lifelong premature ejaculation; a randomized controlled trial. International Journal of Impotence Research. 2024; 36: 864–868.

[32] Sun D, Lu M, Zhang L, Wang Y, Gao X, Zhu S. Primary premature ejaculation of kidney deficiency and liver stagnation treated with warm acupuncture of large-quantity moxibustion: a randomized controlled trial. Chinese Acupuncture & Moxibustion. 2024; 44: 913–918. (In Chinese)

[33] Guo J, Gao QH, Wang F, Yu GJ, Zhang JW, Zeng Y, et al. Efficacy and safety of Qiaoshao Formula on patients with lifelong premature ejaculation of Gan (Liver) depression and Shen (Kidney) deficiency syndrome: a randomized controlled trial. Chinese Journal of Integrative Medicine. 2016; 22: 889–893.

[34] Wang H, Chang H, Ma D, Zhao Z, Wang A, Luo D, et al. Hongjing Qiwei formula combined with tadalafil in the treatment of erectile dysfunction associated with type 2 diabetes mellitus: study protocol for a double-blind, single-dummy, randomized controlled trial. Revista Internacional de Andrología. 2025; 23: 67–74.

[35] Yao X, Xu C, Yang L, Wu A, Xiong L. A review of traditional Chinese medicine intervention methods for depression among college students. Frontiers in Psychology. 2025; 15: 1506965.

[36] Wang H, Zhao M, Zhang J, Yan B, Gao Q, Guo J. Traditional Chinese medicine regulates inflammatory factors in chronic prostatitis/chronic pelvic pain syndrome: a review. Integrative Medicine in Nephrology and Andrology. 2023; 10: e00001.

[37] Ning B, Ge T, Zhao QQ, Feng LS, Wu YQ, Chen H, et al. Research status of pathogenesis of anxiety or depression after percutaneous coronary intervention and Traditional Chinese Medicine intervention. Journal of Ethnopharmacology. 2024; 327: 118017.

[38] Chen J, Huang Y, Li L, Niu J, Ye W, Wang Y, et al. Antidepressant pathways of the Chinese herb jiaweisinisan through genetic ontology analysis. Journal of Integrative Neuroscience. 2020; 19: 385–395.